Skip to main content
. 2021 Apr 15;78(10):4589–4613. doi: 10.1007/s00018-021-03801-1

Table 1.

Mammalian cell lines with Ku70 or Ku80 deficiencies

Subunit Species Cell line/tissue Type of cell line Type of deficiency Viability Reference(s)
Ku70 Human RERF-LC-A1 Immortal Knockdown Viable [58]
Nalm-6 Immortal Heterozygous Viable [59]
HCT116 Immortal Heterozygous Viable [60]
Knockout Inviable
HAP1 Immortal Knockout Inviable [8]
KBM7
Mouse Mouse Embryonic Fibroblasts (MEFs) Immortal Knockout Viable [61]
Embryonic Stem (ES) cells Primary Heterozygous Viable [16]
Knockout
Fibroblasts Primary Heterozygous Viable [62]
Knockout
B and T lymphocytes, thymocytes, MEFs, spleen, bone marrow Primary Knockout Viable [63]
Ku80 Hamster sxi-2, sxi-3 Immortal Knockout Viable [64]
CHO-xrs-6 or xrs6a Immortal Knockout Viable [65, 66]
CHO-xrs-4 or xrs4a
CHO-xrs-5 or xrs5a Immortal Knockdown Viable [66]
XR-V15B Immortal Knockout Viable [67]
XR-V9B Immortal Knockout Viable [68]
Human MRC5V1 Immortal Knockdown Viable [69]
HCT116 Immortal Heterozygous Viable [7]
Knockout Inviable
HeLa Immortal Knockdown Reduced viability [70]
U2OS
SAOS
Nalm-6 Immortal Heterozygous Viable [59]
Mouse MEFs Immortal Knockout Viable [6]
Bone marrow, B and T lymphocytes, MEFs, spleen Primary Knockout Viable [6, 71]
ES cells, fibroblasts, thymus Primary Knockout Viable [6]
Thymocytes Primary Knockout Viable [71]

axrs hamster cell lines can be reverted to wild-type levels of Ku80 with azacytidine treatment suggesting they may not be true knockouts, but instead contain one silenced, but functional allele [66]